Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
The cardiac intravenous program (RGN-352) was placed on FDA clinical hold in March 2011 and never enrolled patients
Lyophilized powder is typically favoured in laboratory settings because it allows precise reconstitution, flexible concentration ranges, and greater control over experimental variables
Key mechanisms include: Angiogenesis Promotion : It up-regulates vascular endothelial growth factor (VEGF), enhancing blood vessel formation to improve nutrient delivery to damaged tissues.[6] Nitric Oxide (NO) Modulation : BPC-157 interacts with the NO system to support vasodilation and anti-thrombotic effects, aiding in wound healing and reducing inflammation.[7] Growth Hormone Receptor Enhancement : It increases expression of growth hormone receptors, facilitating cell proliferation and repair in muscles, tendons, and ligaments.[8] Cytoprotection and Anti-Inflammatory Effects : By protecting cells from toxins (e.g., alcohol, NSAIDs) and modulating inflammatory pathways, it maintains tissue integrity, particularly in the GI tract and central nervous system (CNS).[9] Neuroprotective Interactions : It influences dopamine and glutamate systems, potentially mitigating brain damage from trauma or ischemia.[10] These actions make BPC-157 a versatile agent in regenerative medicine, often compared to "Wolverine-like" healing in anecdotal reports from users
Just how prevalent are peptide therapeutic products
This represents an indirect mechanism that could enhance the bodys natural repair processes rather than replacing them with an external signal
US$ 24.32
US$ 26.32
US$ 29.97
US$ 21.51
US$ 24.05
US$ 22.52
